Long-term tenofovir disoproxil fumarate ( TDF ) treatment for chronic hepatitis B ( CHB ) is associated with sustained viral suppression and regression of fibrosis and cirrhosis at year @ ( @ weeks ) and no TDF resistance through @ years ( @ weeks ) .